Transforming growth factor-beta 1 inhibits murine immediate and delayed type hypersensitivity - PubMed (original) (raw)
. 1992 Jul 15;149(2):521-8.
Affiliations
- PMID: 1624798
Transforming growth factor-beta 1 inhibits murine immediate and delayed type hypersensitivity
R Meade et al. J Immunol. 1992.
Abstract
Transforming growth factor beta 1 (TGF-beta 1) is a member of a gene superfamily that regulates growth, differentiation, and function of cells including several in vitro immune functions. Our study examined the systemic effect of TGF-beta 1 on murine delayed-type hypersensitivity (DTH), a model of T cell-mediated immunity that may depend on mast cells. Mice were immunized by i.v. injection of SRBC or by topical application of picryl chloride, and the responses were elicited by cutaneous challenge with the appropriate Ag. Systemic administration of TGF-beta 1 at the time of Ag challenge significantly reduced both the early and late phases of DTH. The effect of TGF-beta 1 on the release of serotonin from mouse peritoneal mast cells was examined. Results indicated that in vivo treatment with TGF-beta 1 24 h before mast cell harvest inhibited the in vitro release of serotonin in response to challenge with compound 48/80, or anti-IgE antibody. In contrast, treatment with TGF-beta 1 24 h before Ag challenge did not inhibit DTH indicating that mast cells may not be the direct target for TGF-beta 1 in the DTH models. In vivo treatment with TGF-beta 1 inhibited the IgE-mediated, mast cell-dependent, immediate hypersensitivity skin swelling response when injected at the time of, or 24 h before challenge. This suggests an effect on mast cells and a regulatory role for TGF-beta 1 in IgE-mediated responses.
Similar articles
- Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice.
Askenase PW, Van Loveren H, Kraeuter-Kops S, Ron Y, Meade R, Theoharides TC, Nordlund JJ, Scovern H, Gerhson MD, Ptak W. Askenase PW, et al. J Immunol. 1983 Dec;131(6):2687-94. J Immunol. 1983. PMID: 6605986 - A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.
Van Loveren H, Den Otter W, Meade R, Terheggen PM, Askenase PW. Van Loveren H, et al. J Immunol. 1985 Feb;134(2):1292-9. J Immunol. 1985. PMID: 3871209 - Serotonin initiation of delayed-type hypersensitivity: mediation by a primitive Thy-1+ antigen-specific clone or by specific monoclonal IgE antibody.
Askenase PW, Herzog WR, Millet I, Paliwal V, Ramabhadran R, Rochester C, Geba GP, Ptak W. Askenase PW, et al. Skin Pharmacol. 1991;4 Suppl 1:25-42. doi: 10.1159/000210981. Skin Pharmacol. 1991. PMID: 1684905 Review. - A subset of AID-dependent B-1a cells initiates hypersensitivity and pneumococcal pneumonia resistance.
Askenase PW, Bryniarski K, Paliwal V, Redegeld F, Groot Kormelink T, Kerfoot S, Hutchinson AT, van Loveren H, Campos R, Itakura A, Majewska-Szczepanik M, Yamamoto N, Nazimek K, Szczepanik M, Ptak W. Askenase PW, et al. Ann N Y Acad Sci. 2015 Dec;1362(1):200-14. doi: 10.1111/nyas.12975. Ann N Y Acad Sci. 2015. PMID: 26662721 Free PMC article. Review.
Cited by
- Genetic evidence for the role of transforming growth factor-β in atopic phenotypes.
Weissler KA, Frischmeyer-Guerrerio PA. Weissler KA, et al. Curr Opin Immunol. 2019 Oct;60:54-62. doi: 10.1016/j.coi.2019.05.002. Epub 2019 Jun 1. Curr Opin Immunol. 2019. PMID: 31163387 Free PMC article. Review. - Mast cells as sources of cytokines, chemokines, and growth factors.
Mukai K, Tsai M, Saito H, Galli SJ. Mukai K, et al. Immunol Rev. 2018 Mar;282(1):121-150. doi: 10.1111/imr.12634. Immunol Rev. 2018. PMID: 29431212 Free PMC article. Review. - ADAM10 is required for SCF-induced mast cell migration.
Faber TW, Pullen NA, Fernando JF, Kolawole EM, McLeod JJ, Taruselli M, Williams KL, Rivera KO, Barnstein BO, Conrad DH, Ryan JJ. Faber TW, et al. Cell Immunol. 2014 Jul;290(1):80-8. doi: 10.1016/j.cellimm.2014.05.005. Epub 2014 May 21. Cell Immunol. 2014. PMID: 24950026 Free PMC article. - Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathway.
Fernando J, Faber TW, Pullen NA, Falanga YT, Kolawole EM, Oskeritzian CA, Barnstein BO, Bandara G, Li G, Schwartz LB, Spiegel S, Straus DB, Conrad DH, Bunting KD, Ryan JJ. Fernando J, et al. J Immunol. 2013 Nov 1;191(9):4505-13. doi: 10.4049/jimmunol.1202723. Epub 2013 Sep 25. J Immunol. 2013. PMID: 24068671 Free PMC article. - The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling.
Pullen NA, Falanga YT, Morales JK, Ryan JJ. Pullen NA, et al. Front Immunol. 2012 May 11;3:117. doi: 10.3389/fimmu.2012.00117. eCollection 2012. Front Immunol. 2012. PMID: 22593761 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources